Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia

Leukemia

Volumn 24, Issue 3, 2010, Pages 642-645

  Chapiro, E ^a,b,c   Russell, L ^d   Lainey, E ^a,e   Kaltenbach, S ^a,b   Ragu, C ^a,b   Della Valle, V ^a,b   Hanssens, K ^f,g,h,i   MacIntyre, E A ^b,j   Radford Weiss, I ^a,j   Delabesse, E ^a   Cave H ^e   Mercher, T ^a,b   Harrison, C J ^d   Nguyen Khac, F ^c   Dubreuil, P ^f,g,h,i   Bernard, O A ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

^g Centre de Référence des Mastocytoses   (France)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

^j HÔPITAL NECKER ENFANTS MALADES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; JANUS KINASE 2; PROTEIN TSLPR; STAT PROTEIN; UNCLASSIFIED DRUG;

CELL GROWTH; CELL SELECTION; CELL SURFACE; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE TARGETING; GENETIC VARIABILITY; HUMAN; LETTER; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

EID: 77949425065     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.231     Document Type: Letter

References (14)

1. Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009; 23: 1209-1218.
2. Malinge S, Ben-Abdelali R, Settegrana C, Radford-Weiss I, Debre M, Beldjord K, et al. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia. Blood 2007; 109: 2202-2204.
3. Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 2008; 372: 1484-1492.
4. Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M, et al. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood 2009; 113: 646-648.
5. Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B cell precursor acute lymphoblastic leukemia. Blood 2009; 29: 29.
6. Ziegler SF, Liu YJ. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 2006; 7: 709-714.
7. Storlazzi CT, Albano F, Lo Cunsolo C, Doglioni C, Guastadisegni MC, Impera L, et al. Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. Leukemia 2007; 21: 2221-2225.
8. Jamieson CH, Barroga CF, Vainchenker WP. Miscreant myelopro-liferative disorder stem cells. Leukemia 2008; 22: 2011-2019.
9. Kilpivaara O, Levine RL. JAK2 and MPL mutations in myelopro-liferative neoplasms: discovery and science. Leukemia 2008; 22: 1813-1817.
10. Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HF. Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 1992; 89: 2140-2144.
11. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-258.
12. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001; 167: 336-343.
13. Tonozuka Y, Fujio K, Sugiyama T, Nosaka T, Hirai M, Kitamura T. Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR. Cytogenet Cell Genet 2001; 93: 23-25.
14. Malinge S, Ragu C, Della-Valle V, Pisani D, Constantinescu SN, Perez C, et al. Activating mutations in human acute megakaryo-blastic leukemia. Blood 2008; 112: 4220-4226.